Due to the unique ability of CRE‐DR to recognize both human and canine IgE, a dog model of IgE‐mediated allergy could be utilized to investigate the efficacy of anti‐IgE therapeutic mAbs derived from the CRE‐DR. This evidence concerns the gene IGHE and Allergy.